These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11708921)

  • 1. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structure-activity relationship studies on the central 1,3-dioxoperhydropyrido[1,2-c]pyrimidine scaffold.
    Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Cenarruzabeitia E; Latorre M; Del Río J; Herranz R
    J Med Chem; 2001 Nov; 44(24):4196-206. PubMed ID: 11708921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-position.
    Bartolomé-Nebreda JM; Patiño-Molina R; Martín-Martínez M; Gómez-Monterrey I; García-López MT; González-Muñiz R; Cenarruzabeitia E; Latorre M; Del Río J; Herranz R
    J Med Chem; 2001 Jun; 44(13):2219-28. PubMed ID: 11405658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
    Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R
    J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structural modifications at the tryptophan domain.
    Bartolomé-Nebreda JM; Gómez-Monterrey I; García-López MT; González-Muñiz R; Martín-Martínez M; Ballaz S; Cenarruzabeitia E; LaTorre M; Del Río J; Herranz R
    J Med Chem; 1999 Nov; 42(22):4659-68. PubMed ID: 10579828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectivity toward CCK2 receptors.
    Muñoz-Ruiz P; García-López MT; Cenarruzabeitia E; Del Río J; Dufresne M; Foucaud M; Fourmy D; Herranz R
    J Med Chem; 2004 Oct; 47(21):5318-29. PubMed ID: 15456276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally restricted analogues of the potent CCK-B antagonist CI-988.
    Higginbottom M; Hill DR; Horwell DC; Mostafai E; Suman-Chauhan N; Roberts E
    Bioorg Med Chem; 1993 Sep; 1(3):209-17. PubMed ID: 8081854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
    Ursini A; Capelli AM; Carr RA; Cassarà P; Corsi M; Curcuruto O; Curotto G; Dal Cin M; Davalli S; Donati D; Feriani A; Finch H; Finizia G; Gaviraghi G; Marien M; Pentassuglia G; Polinelli S; Ratti E; Reggiani AM; Tarzia G; Tedesco G; Tranquillini ME; Trist DG; Van Amsterdam FT
    J Med Chem; 2000 Oct; 43(20):3596-613. PubMed ID: 11020274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
    Martín-Martínez M; De La Figuera N; Latorre M; Herranz R; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
    J Med Chem; 2000 Oct; 43(20):3770-7. PubMed ID: 11020292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors.
    Kerwin JF; Wagenaar F; Kopecka H; Lin CW; Miller T; Witte D; Stashko M; Nadzan AM
    J Med Chem; 1991 Dec; 34(12):3350-9. PubMed ID: 1766000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
    Boden PR; Higginbottom M; Hill DR; Horwell DC; Hughes J; Rees DC; Roberts E; Singh L; Suman-Chauhan N; Woodruff GN
    J Med Chem; 1993 Mar; 36(5):552-65. PubMed ID: 7684452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second generation "peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.
    Trivedi BK; Padia JK; Holmes A; Rose S; Wright DS; Hinton JP; Pritchard MC; Eden JM; Kneen C; Webdale L; Suman-Chauhan N; Boden P; Singh L; Field MJ; Hill D
    J Med Chem; 1998 Jan; 41(1):38-45. PubMed ID: 9438020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419.
    Tabuchi S; Ito H; Sogabe H; Kuno M; Kinoshita T; Katumi I; Yamamoto N; Mitsui H; Satoh Y
    Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):1-15. PubMed ID: 10705468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.
    Latorre M; Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Herranz R; Del Río J; Cenarruzabeitia E
    Pharmacology; 2004 Oct; 72(2):68-76. PubMed ID: 15331911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988.
    Augelli-Szafran CE; Horwell DC; Kneen C; Ortwine DF; Pritchard MC; Purchase TS; Roth BD; Trivedi BK; Hill D; Suman-Chauhan N; Webdale L
    Bioorg Med Chem; 1996 Oct; 4(10):1733-45. PubMed ID: 8931944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonists.
    Bock MG; DiPardo RM; Newton RC; Bergman JM; Veber DF; Freedman SB; Smith AJ; Chapman KL; Patel S; Kemp JA
    Bioorg Med Chem; 1994 Sep; 2(9):987-98. PubMed ID: 7712133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S; Smith AJ; Chapman KL; Fletcher AE; Kemp JA; Marshall GR; Hargreaves RJ; Ryecroft W; Iversen LL; Iversen SD
    Mol Pharmacol; 1994 Nov; 46(5):943-8. PubMed ID: 7969084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK(2) receptor antagonists containing the conformationally constrained phenylalanine derivatives, including the new amino acid Xic.
    Gibson SE; Guillo N; Jones JO; Buck IM; Kalindjian SB; Roberts S; Tozer MJ
    Eur J Med Chem; 2002 May; 37(5):379-89. PubMed ID: 12008052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
    Low CM; Black JW; Broughton HB; Buck IM; Davies JM; Dunstone DJ; Hull RA; Kalindjian SB; McDonald IM; Pether MJ; Shankley NP; Steel KI
    J Med Chem; 2000 Sep; 43(19):3505-17. PubMed ID: 11000005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.